TGF-β Promotes Heterogeneity and Drug Resistance in Squamous Cell Carcinoma

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590

Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation

Trapnell, C., Williams, B. A., Pertea, G., Mortazavi, A., Kwan, G., van Baren, M. J., Salzberg, S. L., Wold, B. J., & Pachter, L. (2010) · Nature Biotechnology · doi:10.1038/nbt.1621 · Cited by 15,556

Differential gene and transcript expression analysis of RNA-seq experiments with TopHat and Cufflinks

Trapnell, C., Roberts, A., Goff, L. A., Pertea, G. M., Kim, D., Kelley, D. R., Pimentel, H., Salzberg, S. L., Rinn, J. L., & Pachter, L. S. (2012) · Nature Protocols · doi:10.1038/nprot.2012.016 · Cited by 12,145

Immunity, Inflammation, and Cancer

Grivennikov, S. I., Greten, F. R., & Karin, M. (2010) · Cell · doi:10.1016/j.cell.2010.01.025 · Cited by 10,755

The resurgence of platinum-based cancer chemotherapy

Kèlland, L. R. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2167 · Cited by 4,733

Modulation of oxidative stress as an anticancer strategy

Gorrini, C., Harris, I. S., & Mak, T. W. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4002 · Cited by 3,579

TGFβ signalling in context

Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,239

Clonal evolution in cancer

Greaves, M., & Maley, C. C. (2012) · Nature · doi:10.1038/nature10762 · Cited by 3,162

Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

Srinivas, S., Watanabe, T., Lin, C.-S., William, C. M., Tanabe, Y., Jessell, T. M., & Costantini, F. (2001) · BMC Developmental Biology · doi:10.1186/1471-213x-1-4 · Cited by 3,121

Association of reactive oxygen species levels and radioresistance in cancer stem cells

Diehn, M., Cho, R. W., Lobo, N. A., Kalisky, T., Dorie, M. J., Kulp, A. N., Qian, D., Lam, J. S., Ailles, L. E., Wong, M., et al. (2009) · Nature · doi:10.1038/nature07733 · Cited by 2,555

Various Mechanisms Involve the Nuclear Factor (Erythroid-Derived 2)-Like (NRF2) to Achieve Cytoprotection in Long-Term Cisplatin-Treated Urothelial Carcinoma Cell Lines

Skowron, M. A., Niegisch, G., Albrecht, P., van Koeveringe, G. A., Romano, A., Albers, P., Schulz, W. A., & Hoffmann, M. J. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081680 · Cited by 14

Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma

Dudás, J., Riml, A., Tuertscher, R., Pritz, C. O., Steinbichler, T. B., Schartinger, V. H., Sprung, S., Glueckert, R., Schrott‐Fischer, A., Chacko, L. J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020272 · Cited by 14

Intra‐epithelial non‐canonical Activin A signaling safeguards prostate progenitor quiescence

Cambuli, F., Foletto, V., Alaimo, A., Felice, D. D., Gandolfi, F., Palumbieri, M. D., Zaffagni, M., Genovesi, S., Lorenzoni, M., Celotti, M., et al. (2022) · EMBO Reports · doi:10.15252/embr.202154049 · Cited by 14

The roles and mechanisms of TGFB1 in acute myeloid leukemia chemoresistance

Liang, X., Zhou, J., Li, C., Wang, H., Wan, Y., Ling, C., Pu, L., Zhang, W., Fan, M., Hong, J., et al. (2024) · Cellular Signalling · doi:10.1016/j.cellsig.2023.111027 · Cited by 13

Transforming Growth Factor-β/Smad Signaling Inhibits Melanoma Cancer Stem Cell Self-Renewal, Tumor Formation and Metastasis

Boudreault, J., Wang, N., Ghozlan, M., & Lebrun, J. J. (2024) · Cancers · doi:10.3390/cancers16010224 · Cited by 13

The epigenome and the many facets of cancer drug tolerance

Moore, P. C., Henderson, K. W., & Classon, M. (2023) · Advances in cancer research · doi:10.1016/bs.acr.2022.12.002 · Cited by 14

Comprehensive network analysis of the molecular mechanisms associated with sorafenib resistance in hepatocellular carcinoma

Lin, H., Zhang, R., Wu, W., & Lei, L. (2020) · Cancer Genetics · doi:10.1016/j.cancergen.2020.04.076 · Cited by 13

Tumor-initiating stem cells fine-tune the plasticity of neutrophils to sculpt a protective niche

Guo, W., Luan, J., Huang, X., Leon, D., Gang, S., Nicholson, B., Bertacchi, B., Bolotin, D., Lingen, M. W., Pearson, A. T., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.11.001 · Cited by 12

Skin in the Game: Stem Cells in Repair, Cancer, and Homeostasis

Horsley, V. (2020) · Cell · doi:10.1016/j.cell.2020.03.019 · Cited by 12

NRF3 suppresses squamous carcinogenesis, involving the unfolded protein response regulator HSPA5

Gurri, S., Siegenthaler, B., Cangkrama, M., Restivo, G., Huber, M., Saliba, J., Dummer, R., Blank, V., Hohl, D., & Werner, S. (2023) · EMBO Molecular Medicine · doi:10.15252/emmm.202317761 · Cited by 12

CD133+PD-L1+ cancer cells confer resistance to adoptively transferred engineered macrophage-based therapy in melanoma

Xu, J., Li, Z., Tong, Q., Zhang, S., Fang, J., Wu, A., Wei, G., Zhang, C., Yu, S., Zheng, B., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55876-0 · Cited by 15

TGF-β-Induced TMEPAI Promotes Epithelial–Mesenchymal Transition in Doxorubicin-Treated Triple-Negative Breast Cancer Cells via SMAD3 and PI3K/AKT Pathway Alteration

Wardhani, B. W. K., Louisa, M., Watanabe, Y., Setiabudy, R., & Kato, M. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s325429 · Cited by 12

Oh, the Mutations You’ll Acquire! A Systematic Overview of Cutaneous Squamous Cell Carcinoma

Droll, S. H., & Bao, X. (2021) · Cellular Physiology and Biochemistry · doi:10.33594/000000433 · Cited by 12

Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies

Cavalieri, S., Filippini, D. M., Ottini, A., Bergamini, C., Resteghini, C., Colombo, E. V., Lombardo, R., Nuzzolese, I., Alfieri, S., Licitra, L. F., et al. (2021) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2021.00062 · Cited by 12

Cancer Stem Cells Contribute to Drug Resistance in Multiple Different Ways

Zahra, M. H., Nawara, H. M., Hassan, G., Afify, S. M., Seno, A., & Seno, M. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-12974-2_6 · Cited by 12

Therapy-Induced Transdifferentiation Promotes Glioma Growth Independent of EGFR Signaling

Oh, H., Hwang, I., Jang, J.-Y., Wu, L., Cao, D., Yao, J., Ying, H., Li, J. Y., Yao, Y., Hu, B., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-1810 · Cited by 11

CYR61 confers chemoresistance by upregulating survivin expression in triple-negative breast cancer

Kim, H., Son, S., Ko, Y., Lim, H., Lee, J., Lee, K., & Shin, I. (2024) · Carcinogenesis · doi:10.1093/carcin/bgae013 · Cited by 11

Bioprinted Fibroblast Mediated Heterogeneous Tumor Microenvironment for Studying Tumor‐Stroma Interaction and Drug Screening

Chen, Y., Xue, Y., Yan, C., Jin, J., Liu, Y., Li, J., Han, S., & Liu, J. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202404642 · Cited by 12

Oxidative Stress and the Intersection of Oncogenic Signaling and Metabolism in Squamous Cell Carcinomas

Choe, J. H., Mazambani, S., Kim, T. H., & Kim, J. (2021) · Cells · doi:10.3390/cells10030606 · Cited by 14

Regulation of temozolomide resistance via lncRNAs: Clinical and biological properties of lncRNAs in gliomas (Review)

Sui, L., Xie, X., Fu, P., Du, J., & Peng, C. Y. (2022) · International Journal of Oncology · doi:10.3892/ijo.2022.5391 · Cited by 11

Targeting the mitochondrial calcium uniporter inhibits cancer progression and alleviates cisplatin resistance in esophageal squamous cell carcinoma

Miao, Y., Wang, X., Lai, Y., Huang, Y., Yin, H., Meng, X., Liu, H., Hou, R., Lin, W., Zhang, X., et al. (2023) · International Journal of Oncology · doi:10.3892/ijo.2023.5530 · Cited by 11

Polysulfide nanoparticles inhibit fibroblast-to-myofibroblast transition via extracellular ROS scavenging and have potential anti-fibrotic properties

Siani, A., Infante-Teixeira, L., d’Arcy, R., Roberts, I. V., Mohtadi, F. E., Donno, R., & Tirelli, N. (2023) · Biomaterials Advances · doi:10.1016/j.bioadv.2023.213537 · Cited by 12

Current status and future prospects of transforming growth factor‐β as a potential prognostic and therapeutic target in the treatment of breast cancer

Amerizadeh, F., Bahrami, A., Khazaei, M., Hesari, A., Rezayi, M., Talebian, S., Maftouh, M., Moetamani‐Ahmadi, M., Seifi, S., Shahidsales, S., et al. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27831 · Cited by 10

Characterisation of an Isogenic Model of Cisplatin Resistance in Oesophageal Adenocarcinoma Cells

Buckley, A. M., Bibby, B. A. S., Dunne, M. R., Kennedy, S. A., Davern, M., Kennedy, B. N., Maher, S. G., & O'Sullivan, J. N. (2019) · Pharmaceuticals · doi:10.3390/ph12010033 · Cited by 11

Spatial Distribution of Immune Cells in Head and Neck Squamous Cell Carcinomas

Idel, C., Ribbat‐Idel, J., Klapper, L., Krupar, R., Bruchhage, K., Dreyer, E., Rades, D., Polasky, C., Offermann, A., Kirfel, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.712788 · Cited by 11

Rapamycin enhances the antiproliferative effect of transforming growth factor-β on MCF-7 human breast cancer cells

Wang, G., & Yin, T. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4557 · Cited by 10

Cancer Stem Cell Niche in Colorectal Cancer and Targeted Therapies

Wang, H., Cui, G., Yu, B., Sun, M., & Yang, H. Y. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200408102305 · Cited by 11

Natural bioactive molecules and chemotherapeutics synergism for enhanced cancer therapy

Hashemi, M., Heshmatzad, K., Shahsavan, G., Tavakolpour, V., Esfahani, S. K., Karimi, P., Beikzadeh, N., Mashhadikhan, S., Nasirzade, S., Farahani, A. V., et al. (2026) · Nutrition & Metabolism · doi:10.1186/s12986-026-01094-4 · Cited by 11

Comparison of the tumor microenvironments of squamous cell carcinoma at different anatomical locations within the upper aerodigestive tract in relation to response to ICI therapy

van Duijvenvoorde, M., Sarah Derks, A., Bahce, I., Leemans, C. R., van de Ven, R., & Fransen, M. F. (2022) · Clinical & Translational Immunology · doi:10.1002/cti2.1363 · Cited by 10

Activation of the TGF-β1/EMT signaling pathway by claudin-1 overexpression reduces doxorubicin sensitivity in small cell lung cancer SBC-3 cells

Nagaoka, Y., Oshiro, K., Yoshino, Y., Matsunaga, T., Endo, S., & Ikari, A. (2023) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2023.109824 · Cited by 10

Cancer stem-like cells stay in a plastic state ready for tumor evolution

Xu, J., Zhang, H., Nie, Z., He, W., Zhao, Y., Huang, Z., Jia, L., Du, Z., Zhang, B., & Xia, S. (2025) · Neoplasia · doi:10.1016/j.neo.2025.101134 · Cited by 10

Co-targeting BMI1 and MYC to eliminate cancer stem cells in squamous cell carcinoma

Qin, Z., Liu, S., Zheng, Y., Wang, Y., Chen, Y., Peng, X., & Jia, L. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102077 · Cited by 10

Role of exosomes in transforming growth factor-β-mediated cancer cell plasticity and drug resistance

Ruksha, T. G., & Palkina, N. V. (2025) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2025.1002322 · Cited by 13

Lefty A is involved in sunitinib resistance of renal cell carcinoma cells via regulation of IL-8

Cui, N., Han, Q., Cao, Q., Wang, K., Zhou, X., Hou, P., Liu, C., Chen, L., & Xu, L. (2021) · Biological Chemistry · doi:10.1515/hsz-2021-0280 · Cited by 10

Modeling the effects of EMT-immune dynamics on carcinoma disease progression

Bergman, D. R., Karikomi, M. K., Yu, M., Nie, Q. H., & MacLean, A. L. (2021) · Communications Biology · doi:10.1038/s42003-021-02499-y · Cited by 9

Lipidome-based rapid diagnosis with machine learning for detection of TGF-β signalling activated area in head and neck cancer

Ishii, H., Saitoh, M., Sakamoto, K., Sakamoto, K., Saigusa, D., Kasai, H., Ashizawa, K., Miyazawa, K., Takeda, S., Masuyama, K., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0732-y · Cited by 10

Volume imaging to interrogate cancer cell-tumor microenvironment interactions in space and time

Almagro, J., & Messal, H. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1176594 · Cited by 10

The molecular mechanisms of chemotherapeutic resistance in tumors (Review)

Weng, X., Zeng, W.-H., Zhong, L., Xie, L., Ge, W.-J., Lai, Z., Qin, Q., Liu, P., Cao, D., & Zeng, X. (2024) · Oncology Reports · doi:10.3892/or.2024.8816 · Cited by 9

Cancer stem cells: Masters of all traits

Leck, L. Y. W., El-Aziz, Y. S. A., McKelvey, K. J., Park, K. C., Sahni, S., Lane, D. J. R., Skoda, J., & Jansson, P. J. (2024) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2024.167549 · Cited by 9

Comparative subcellular localization of NRF2 and KEAP1 during the hepatocellular carcinoma development in vivo

Guerrero‐Escalera, D., Alarcón‐Sánchez, B. R., Arellanes‐Robledo, J., Cruz‐Rangel, A., del Pozo‐Yauner, L., de Sánchez, V. C., Reséndis-Antonio, O., Villa‐Treviño, S., Torres‐Mena, J. E., & Pérez‐Carreón, J. I. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2022.119222 · Cited by 9

Family with sequence similarity 46 member a confers chemo-resistance to ovarian carcinoma via TGF-β/Smad2 signaling

Liang, S., Liu, Y.-Y., He, J., Gao, T. M., Li, L., & He, S. (2022) · Bioengineered · doi:10.1080/21655979.2022.2064652 · Cited by 9

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

Um‐e‐Kalsoom, Wang, S., Qu, J., & Liu, L. (2024) · Cancer Medicine · doi:10.1002/cam4.70155 · Cited by 8

Prognostic impact and potential predictive role of baseline circulating tumor cells in locally advanced head and neck squamous cell carcinoma

de Oliveira, T. B., Braun, A. C., Nicolau, U. R., Abdallah, E. A., Alves, V. S., de Jesus, V. H. F., Calsavara, V. F., Kowaslki, L. P., & Chinen, L. T. D. (2021) · Oral Oncology · doi:10.1016/j.oraloncology.2021.105480 · Cited by 9

A Comparative Endocrine Trans-Differentiation Approach to Pancreatic Ductal Adenocarcinoma Cells with Different EMT Phenotypes Identifies Quasi-Mesenchymal Tumor Cells as Those with Highest Plasticity

Schmidtlein, P. M., Volz, C., Braun, R., Thürling, I., Lapshyna, O., Wellner, U. F., Konukiewitz, B., Lehnert, H., Marquardt, J.-U., & Ungefroren, H. (2021) · Cancers · doi:10.3390/cancers13184663 · Cited by 9

The Role of Pulmonary Veins in Cancer Progression from a Computed Tomography Viewpoint

Liaw, C., Chang, H., Liao, T.-Y., Wen, M.-S., Yu, C., & Juan, Y. (2016) · Journal of Oncology · doi:10.1155/2016/1872627 · Cited by 9

Oleanolic acid inhibits aldo-keto reductase family 1 member B10-induced cancer stemness and avoids cisplatin-based chemotherapy resistance via the Snail signaling pathway in oral squamous cell carcinoma cell lines

Ko, H., Chou, H., Hou, H., Kuo, W., Liu, W., Kuo, M. Y., & Cheng, S. (2024) · Journal of Dental Sciences · doi:10.1016/j.jds.2024.09.018 · Cited by 8

METTL3 ‐mediated ALDH m 6 A methylation regulates the malignant behavior of BMI1 + HNSCC stem cells

Chen, Z., Chen, J., Xu, X., Li, Q., Zhang, C., Li, S., Liu, L., Cao, C., Chen, D., & He, Q. (2023) · Oral Diseases · doi:10.1111/odi.14609 · Cited by 8

Tumorigenic effects of human mesenchymal stromal cells and fibroblasts on bladder cancer cells

Frerichs, L. M., Frerichs, B., Petzsch, P., Köhrer, K., Windolf, J., Bittersohl, B., Hoffmann, M. J., & Grotheer, V. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1228185 · Cited by 9

Single-cell decoding of drug induced transcriptomic reprogramming in triple negative breast cancers

Kabeer, F., Tran, H., Andronescu, M., Singh, G., Lee, H., Salehi, S., Wang, B., Biele, J., Brimhall, J., Gee, D., et al. (2024) · Genome biology · doi:10.1186/s13059-024-03318-3 · Cited by 9

Desquamation takes center stage at the origin of proliferative inflammatory atrophy, epithelial–mesenchymal transition, and stromal growth in benign prostate hyperplasia

Ferrucci, D. L., Biancardi, M. F., Nishan, U., Rosa‐Ribeiro, R., & Carvalho, H. F. (2017) · Cell Biology International · doi:10.1002/cbin.10867 · Cited by 8

ADAP1 promotes invasive squamous cell carcinoma progression and predicts patient survival

Duzer, A. V., Taniguchi, S., Elhance, A., Tsujikawa, T., & Oshimori, N. (2019) · Life Science Alliance · doi:10.26508/lsa.201900582 · Cited by 8

TROY Modulates Cancer Stem-Like Cell Properties and Gefitinib Resistance Through EMT Signaling in Non–Small Cell Lung Cancer

Wu, L., Yu, Y., Xu, L., Wang, X., Zhou, J., & Wang, Y. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.881875 · Cited by 8

SMAD3silencing enhances DNA damage in radiation therapy by interacting withMRE11-RAD50-NBS1complex in glioma

Jiang, Z., Guo, Y., Miao, L., Han, L., Zhang, W., & Jiang, Y. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy110 · Cited by 8

Prognostic Significance of CD109 Expression in Patients with Ovarian Epithelial Cancer

Kim, S. Y., Choi, K. U., Hwang, C., Lee, H. J., Lee, J. H., Shin, D., Kim, J. Y., Sol, M. Y., Kim, J. H., Kim, K. H., et al. (2019) · Journal of Pathology and Translational Medicine · doi:10.4132/jptm.2019.04.16 · Cited by 8

High expression of PSF1 promotes drug resistance and cell cycle transit in leukemia cells

Hsieh, H., Jia, W., Jin, Z., Kidoya, H., & Takakura, N. (2020) · Cancer Science · doi:10.1111/cas.14452 · Cited by 8

PROX1 induction by autolysosomal activity stabilizes persister-like state of colon cancer via feedback repression of the NOX1-mTORC1 pathway

Ohata, H., Shiokawa, D., Sakai, H., Kanda, Y., Okimoto, Y., Kaneko, S., Hamamoto, R., Nakagama, H., & Okamoto, K. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112519 · Cited by 7

Global trends in research of nasopharyngeal carcinoma: a bibliometric and visualization analysis

An, G., Liu, J., Lin, T., He, L., & He, Y. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1392245 · Cited by 7

Three-dimensional Imaging Reveals Immune-driven Tumor-associated High Endothelial Venules as a Key Correlate of Tumor Rejection Following Depletion of Regulatory T Cells

Milutinovic, S., Abe, J., Jones, E., Kelch, I. D., Smart, K., Lauder, S. N., Somerville, M. S., Ware, C. F., Godkin, A. J., Stein, J. V., et al. (2022) · Cancer Research Communications · doi:10.1158/2767-9764.crc-21-0123 · Cited by 8

First‐in‐human study of E7130 (a tumor microenvironment‐ameliorating microtubule inhibitor) in patients with advanced solid tumors: Primary results of the dose‐escalation part

Doi, T., Matsubara, N., Naito, Y., Kuboki, Y., Harano, K., Ono, M., Urasaki, T., Ohmoto, A., Kawanai, T., Hisai, T., et al. (2023) · Cancer · doi:10.1002/cncr.34788 · Cited by 7

One week’s holiday sun exposure induces expression of photoaging biomarkers

Lesiak, A., Rogowski-Tylman, M., Danilewicz, M., Woźniacka, A. J., & Narbutt, J. (2015) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2016.0001 · Cited by 7

Search for Master Regulators in Walking Cancer Pathways

Kel, A. E. (2017) · Methods in molecular biology · doi:10.1007/978-1-4939-7027-8_8 · Cited by 7

Multiplex fluorescent immunohistochemistry quantitatively analyses microvascular density (MVD) and the roles of TGF-β signalling in orchestrating angiogenesis in colorectal cancer

Yang, L., Liu, Z., & Wen, T. (2019) · Translational Cancer Research · doi:10.21037/tcr.2019.02.09 · Cited by 7

Determinants, mechanisms, and functional outcomes of myeloid cell diversity in cancer

Caronni, N., Montaldo, E., Mezzanzanica, L., Cilenti, F., Genua, M., & Ostuni, R. (2021) · Immunological Reviews · doi:10.1111/imr.12944 · Cited by 6

Deconvolution of tumor composition using partially available DNA methylation data

He, D., Chen, M., Wang, W., Song, C., & Qin, Y. (2022) · BMC Bioinformatics · doi:10.1186/s12859-022-04893-7 · Cited by 6

Comprehensive bioinformatics analysis combined with experimental validation to screen biomarkers for malignant transformation of oral leukoplakia

Li, F., Qiu, L., Gao, Q., Yu, L., Liu, H., Xue, Z., & Tao, A. (2023) · Genomics · doi:10.1016/j.ygeno.2023.110686 · Cited by 6

Energy Landscape Reveals the Underlying Mechanism of Cancer‐Adipose Conversion in Gene Network Models

Chen, Z., Lu, J., Zhao, X., Yu, H., & Li, C. (2024) · Advanced Science · doi:10.1002/advs.202404854 · Cited by 6

Machine learning-based bulk RNA analysis reveals a prognostic signature of 13 cell death patterns and potential therapeutic target of SMAD3 in acute myeloid leukemia

Bao, X., Chen, Y., Chang, J., Du, J., Yang, C., Wu, Y., Yu, S., Li, M., Chen, S., Yang, M., et al. (2025) · BMC Cancer · doi:10.1186/s12885-025-13658-3 · Cited by 6

A mechanistic basis for the malignant progression of salivary gland tumors

Taniguchi, S., Tanaka, Y., Elhance, A., & Oshimori, N. (2021) · iScience · doi:10.1016/j.isci.2021.103508 · Cited by 6

CTHRC1 is associated with immune cell infiltration and functions as an adverse marker for prognosis in head and neck squamous cell carcinoma

Zhong, R., Yang, M., Zhu, R., Zhang, J., & Wang, L. (2023) · Oncology Letters · doi:10.3892/ol.2023.13719 · Cited by 6

Polysaccharides from Lentinus edodes prevent acquired drug resistance to docetaxel in prostate cancer cells by decreasing the TGF-β1 secretion of cancer-associated fibroblasts

Zhang, W., Tao, N., & Bai, L. (2023) · Journal of Natural Medicines · doi:10.1007/s11418-023-01722-w · Cited by 6

TGF-β induced reprogramming and drug resistance in triple-negative breast cells

Wu, G., & Li, Y. (2022) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-022-00561-x · Cited by 7

An oxidized dextran and thiolated chitosan-based hydrogel driven biomimetic triple negative breast cancer 3D in vitro model for cancer progression and therapeutic studies

Modi, U., Makwana, P., Dhimmar, B., Ramu, S., Jolly, M. K., & Vasita, R. (2025) · Journal of Materials Chemistry B · doi:10.1039/d5tb00812c · Cited by 5

Fetal reversion from diverse lineages sustains the intestinal stem cell pool and confers stress resilience

Kirino, S., Uefune, F., Miyake, K., Ogasawara, N., Kobayashi, S., Watanabe, S., Hiraguri, Y., Ito, G., Akahoshi, K., Ban, D., et al. (2026) · Communications Biology · doi:10.1038/s42003-026-09533-x · Cited by 10

Precision redox oncology: Exploiting antioxidant dependencies and oxidative vulnerabilities in cancer

Sulaiman, S. H., Omer, R. A., Barzani, K. I. S., Barzani, H. A. H., Ashfaq, M., Smerat, A., & Feizi‐Dehnayebi, M. (2026) · Chemical Physics Impact · doi:10.1016/j.chphi.2026.101054 · Cited by 6

Suppression of lysosome metabolism-meditated GARP/TGF-β1 complexes specifically depletes regulatory T cells to inhibit breast cancer metastasis

Ma, J., Chen, Y., Li, T., Cao, Y., Hu, B., Liu, Y., Zhang, Y., Li, X., Liu, J., Zhang, W., et al. (2024) · Oncogene · doi:10.1038/s41388-024-03043-y · Cited by 5

GPLD1+ cancer stem cells contribute to chemotherapy resistance and tumour relapse in intestinal cancer

Mizoo, T., Oka, T., Sugahara, O., Minato, T., Higa, T., & Nakayama, K. I. (2024) · The Journal of Biochemistry · doi:10.1093/jb/mvae082 · Cited by 5

A quiescence-like/TGF-β1-specific CRISPRi screen reveals drug uptake transporters as secondary targets of kinase inhibitors in AML

Rahimian, E., Koochak, M., Traikov, S., Schroeder, M., Brilloff, S., Schäfer, S., Kufrin, V., Küchler, S., Krüger, A., Mirtschink, P., et al. (2025) · Drug Resistance Updates · doi:10.1016/j.drup.2025.101242 · Cited by 5

Signaling pathways as the pivotal regulators of cisplatin resistance in tumor cells through SOX2 upregulation

Taghehchian, N., Akhlaghipour, I., Zangouei, A. S., Yazdi, M. P., & Moghbeli, M. (2025) · Medical Oncology · doi:10.1007/s12032-025-03004-9 · Cited by 5

TGF ‐β Enhances Doxorubicin Resistance and Anchorage‐Independent Growth in Cancer Cells by Inducing ALDH1A1 Expression

Yokoyama, T., Saitoh, M., & Miyazawa, K. (2025) · Cancer Science · doi:10.1111/cas.70109 · Cited by 5

Identifying drug resistant cancer cells using microbubble well arrays

Pu, Q., Spooner, R., & DeLouise, L. A. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0160-9 · Cited by 5

Obg-like ATPase 1 inhibited oral carcinoma cell metastasis through TGFβ/SMAD2 axis in vitro

Liu, J., Yang, Q., Xiao, K. C., Dobleman, T. J., Hu, S., & Xiao, G. G. (2020) · BMC Molecular and Cell Biology · doi:10.1186/s12860-020-00311-z · Cited by 5

A Review of the Mechanisms of Wnt7b in the Process of Malignant Tumor Invasion and Metastasis

Song, T., Yang, J., Zhou, J., Chen, Z., & Yuan, X. (2019) · International Journal of Pharmacology · doi:10.3923/ijp.2019.523.532 · Cited by 5

Epithelial to Mesenchymal Transition

Dalton, A. C., & Howe, P. H. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00005-0 · Cited by 6

Tumor cell-organized fibronectin is required to maintain a dormant breast cancer populationPreprint

Barney, L. E., Hall, C. L., Schwartz, A. D., Parks, A. N., Sparages, C., Galarza, S., Platt, M. O., Mercurio, A. M., & Peyton, S. R. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/686527 · Cited by 5

NANOS1 restricts oral cancer cell motility and TGF-ß signaling

Rosemann, J., Pyko, J., Jacob, R., Macho, J., Kappler, M., Eckert, A. W., Hämmerle, M., & Gutschner, T. (2024) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2024.151400 · Cited by 4

Diverse Biological Processes Contribute to Transforming Growth Factor β-Mediated Cancer Drug Resistance

Heiserman, J. P., & Akhurst, R. J. (2025) · Cells · doi:10.3390/cells14191518 · Cited by 4

Oncogenic Ras activation in permissive somatic cells triggers rapid-onset phenotypic plasticity and elicits a tumor-promoting neutrophil response

Elliot, A. M., Bravo, I. R., Zhao, Y., Wang, Z., Johansson, J. A., Hutton, E., Cunningham, R., Myllymäki, H., Chang, K.-M., Cholewa-Waclaw, J., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116478 · Cited by 5

Prognostic Genomic Markers of Pathological Stage in Oral Squamous Cell Carcinoma

Kuk, S. K., Lee, J. I., & Kim, K. (2022) · Head and Neck Pathology · doi:10.1007/s12105-022-01516-8 · Cited by 4

Genomic Profiling of the Hallmarks of Cancer

Dib, E. G., Bekkerman, M., Abbas, J., Shanmugasundaram, M., Banerjee, D., He, G., Slabý, O., Elsherif, M. A., & Ge, M. (2024) · Precision Oncogenomics · doi:10.1080/28354311.2023.2264176 · Cited by 4

Progress of Cancer Stem Cells in Retinoblastoma

Wang, N., & Ma, J. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/011574888x252989230921065809 · Cited by 3

Unveiling stem-like traits and chemoresistance mechanisms in ovarian cancer cells through the TGFβ1-PITX2A/B signaling axis

Ghosh, S., Tanbir, S. K. E., Mitra, T., & Roy, S. S. (2024) · Biochemistry and Cell Biology · doi:10.1139/bcb-2024-0010 · Cited by 3

Discovery of drug transporter inhibitors tied to long noncoding RNA in resistant cancer cells; a computational model -in silico- study

Diab, M., Hamdi, A., Al-Obeidat, F. N., Hafez, W., Chérrez-Ojeda, I., Gador, M., Rashid, G., Elkhazin, S. F., Ibrahim, M. A., Ismail, T. F., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1511029 · Cited by 3

Tenascin-C Expression in Relation to Tumor-Stroma Interaction in Ameloblastoma

Sumi, S., Yoshimoto, S., Suyama, K., Taguchi, M., Morita, H., Hiraki, A., & Oka, K. (2025) · Laboratory Investigation · doi:10.1016/j.labinv.2025.104237 · Cited by 3

High-Resolution 3D Heart Models of Cardiomyocyte Subpopulations in Cleared Murine Heart

Ren, H., Pu, Z., Sun, T., Chen, T., Liu, L., Liu, Z., O’Shea, C., Pavlović, D., Tan, X., & Lei, M. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.779514 · Cited by 3

Panoramic view of key cross-talks underpinning the oral squamous cell carcinoma stemness - unearthing the future opportunities

Vastrad, S. J., Ritesh, G., Sowmya, S., V, Saraswathy, G. R., Augustine, D., Alzahrani, K. J., Alzahrani, F. M., Halawani, I. F., Ashi, H. M., Alshahrani, M., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1247399 · Cited by 3

Diurnal variations of neurokinin-1 receptor defines dosing time-dependent differences in antitumor effects of aprepitant in mice

Seto, Y., Tokeshi, S., Inoue, D., Okazaki, F., & To, H. (2025) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2025.04.007 · Cited by 2

TGF-β3 promotes vascular normalization of prostate cancer to potentiate immunotherapy and chemotherapy

Teng, Q., Wang, N., Lei, H., Tong, T., Guan, Y., Huang, M., Cao, F., Xu, B., Yang, J., Huo, Y., et al. (2025) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-025-04103-2 · Cited by 2

Organoid Models of the Oral Mucosa for Precision Medicine

Atwa, A., Wadan, A. S., Hallool, S. I., Shati, A. A., Elbehairi, S. E. I., Alfaifi, M. Y., & Hussein, A. M. (2026) · Tissue Engineering Part B Reviews · doi:10.1177/19373368261420588 · Cited by 3

The histone demethylase KDM4A promotes esophageal cancer progression by epigenetically activating LRG1-mediated TGF-β signaling

Han, Y., Wang, H. W., Guo, Y., Zhang, H., Wen, X., Zhang, M., Hao, J., Hao, J., Qiu, M., Ren, L., et al. (2026) · APOPTOSIS · doi:10.1007/s10495-026-02294-2 · Cited by 2

The Signaling Networks of TIM-3, TGF-β, and STING in Glioblastoma

Ahmady, F., Carnie, B. M. H., Anderson, G. E. C., Achari, E., Sharma, A., Achuthan, A. A., Kannourakis, G., & Luwor, R. B. (2026) · Cells · doi:10.3390/cells15110991 · Cited by 2

Abstract LB-146: TGF-β-induced tumor heterogeneity and drug resistance of cancer stem cells

Oshimori, N., Oristian, D., & Fuchs, E. V. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-lb-146

TGF-β-Induced Quiescence Mediates Chemoresistance of Tumor-Propagating Cells in Squamous Cell Carcinoma

Brown, J. A., Yonekubo, Y., Hanson, N. C., Sastre-Perona, A., Basin, A., Rytlewski, J. A., Dolgalev, I., Meehan, S. A., Tsirigos, A., Beronja, S., et al. (2017) · Cell stem cell · doi:10.1016/j.stem.2017.10.001 · Cited by 165

Cancer stem cells and their niche in the progression of squamous cell carcinoma

Oshimori, N. (2020) · Cancer Science · doi:10.1111/cas.14639 · Cited by 38

Breast Cancer Cells Respond Differentially to Modulation of TGFβ2 Signaling after Exposure to Chemotherapy or Hypoxia

O’Brien, S., Chen, L., Zhong, W., Armellino, D. C., Yu, J., Loreth, C., Follettie, M. T., & Damelin, M. I. (2015) · Cancer Research · doi:10.1158/0008-5472.can-15-0650 · Cited by 10

Smad Protein Expression and Activation in Transforming Growth Factor-β Refractory Human Squamous Cell Carcinoma Cells

Wu, Y., Vellucci, V. F., & Reiss, M. (2001) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504001108747639 · Cited by 24